Crossmark

Safety and tolerability of fingolimod in patients with relapsing-remitting multiple sclerosis: results of an open-label clinical trial in Italy

Crossref DOI link: https://doi.org/10.1007/s10072-016-2701-z

Published Online: 2016-10-18

Published Print: 2017-01

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Laroni, Alice

Brogi, Davide

Brescia Morra, Vincenzo

Guidi, Leonello

Pozzilli, Carlo

Comi, Giancarlo

Lugaresi, Alessandra

Turrini, Renato

Raimondi, Debora

Uccelli, Antonio

Mancardi, Giovanni Luigi https://orcid.org/0000-0001-8427-118X
Funding

Funding for this research was provided by:

Novartis Farma
License Information

License valid from 2016-10-18